Bachem announced today the forthcoming acquisition of American Peptide Company (APC), based in California. The Japanese seller ILS, a wholly-owned subsidiary of Otsuka Chemical, and the buyer, Bachem Americas have signed a contract to transfer all shares of APC. Both parties have agreed not to disclose the terms of the deal.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
BASF sells a majority stake in its coatings business to the investor Carlyle.
